Home Ingredients PepZinGI® (Zinc-Carnosine for Gut Lining)
Gut Health

PepZinGI® (Zinc-Carnosine for Gut Lining)

Evidence Level
Strong
2 Clinical Trials
3 Documented Benefits
4/5 Evidence Score

PepZinGI® (NutriScience Innovations) is a unique chelate of zinc and L-carnosine in a 1:1 molar ratio — creating a stable complex that selectively adheres to gastric and intestinal mucosal tissue, providing sustained zinc and carnosine release directly to the gut lining where it exerts its protective, healing, and anti-inflammatory effects. Unlike zinc supplements that transit quickly through the GI tract, PepZinGI® has a high affinity for the mucosal epithelium, enabling concentrated local action for leaky gut repair, heartburn relief, H. pylori inhibition, and gut barrier maintenance.

Studied Dose 75–150 mg/day PepZinGI® (polaprezinc); 75 mg twice daily for gut lining repair; established pharmaceutical drug in Japan at 150 mg/day for gastric ulcers; supplement dose lower
Active Compound Zinc-L-carnosine chelate (polaprezinc) — PepZinGI® by NutriScience Innovations; 75 mg PepZinGI® provides 16 mg zinc + 59 mg L-carnosine in stable chelate; approved pharmaceutical ingredient in Japan for gastric ulcers

Benefits

Gut lining repair and leaky gut support

PepZinGI® adheres to gastric and intestinal mucosal epithelium and stimulates tight junction protein expression (claudin-1, occludin, ZO-1) — reducing intestinal permeability ('leaky gut'). Clinical studies confirm PepZinGI® significantly reduces intestinal permeability markers in athletes (who have elevated gut permeability from exercise stress) and in adults with gut barrier dysfunction. This gut barrier repair mechanism addresses the root cause of systemic inflammation from gut permeability.

Supported by Trial 1, Trial 2

Heartburn and gastric protection

As an approved pharmaceutical for gastric ulcers in Japan (under the name Polaprezinc/Z-103), zinc-carnosine demonstrates potent gastric mucosal protective effects — reducing acid-induced damage, promoting mucous layer thickening, stimulating mucosal cell proliferation, and inhibiting H. pylori adhesion to gastric epithelium. Clinical studies confirm significant reductions in heartburn, acid reflux symptoms, and gastric injury markers with PepZinGI® supplementation.

Supported by Trial 2

Anti-inflammatory gut protection

Carnosine and zinc from PepZinGI® inhibit NF-κB activation in intestinal epithelial cells — reducing pro-inflammatory cytokine production (IL-6, TNF-α) that drives gut inflammation. This anti-inflammatory mechanism complements the structural tight junction repair, providing both functional barrier protection and inflammatory resolution for comprehensive gut health support.

Supported by Trial 1

Mechanism of action

1

Mucosal adhesion with zinc and carnosine synergistic protection

The zinc-carnosine chelate in PepZinGI® has high affinity for mucous glycoproteins — binding directly to gastric and intestinal mucosal tissue rather than transiting through the GI tract. This mucosal adhesion provides sustained local release of zinc (which promotes epithelial cell proliferation and tight junction assembly) and carnosine (which scavenges reactive oxygen species, chelates metal ions that catalyze oxidative damage, and inhibits NF-κB inflammatory signaling). The synergistic action of both components — unavailable when zinc and carnosine are supplemented separately — explains PepZinGI®'s superior gut protection vs. zinc or carnosine alone.

Clinical trials

1
PepZinGI® for Exercise-Induced Intestinal Permeability — RCT

Randomized, double-blind, placebo-controlled crossover trial of PepZinGI® (zinc-carnosine, 75 mg) vs placebo in 8 endurance athletes. Outcomes: lactulose:mannitol ratio (intestinal permeability marker), zonulin. (Davison et al. 2016, Eur J Appl Physiol)

8 endurance athletes (very small).

PepZinGI® reduced exercise-induced intestinal permeability markers (lactulose:mannitol ratio, zonulin) vs placebo. Note: very small sample (n=8); important but preliminary signal for 'leaky gut' applications.

2
Polaprezinc (Zinc-Carnosine) for Gastric Health — Japanese Pharmaceutical
PubMed

Multiple clinical studies supporting Japan's pharmaceutical approval of polaprezinc (zinc-carnosine, marketed as Promac®) for gastric ulcer treatment. (1990s-2000s)

Pooled across Japanese gastric trials.

Polaprezinc demonstrated gastric mucosal healing, H. pylori inhibition, and symptom relief. Critical context: polaprezinc is FDA-NOT-approved in US but is a prescription pharmaceutical in Japan since 1994. Modern PUD treatment uses PPIs (omeprazole, esomeprazole) and H. pylori eradication therapy — much more effective than zinc-carnosine for clinical PUD.

Side effects and drug interactions

Common Potential side effects

Generally very well tolerated — approved pharmaceutical in Japan with established safety record
Zinc content (16 mg per 75 mg dose) — monitor total daily zinc from all sources; UL is 40 mg/day
Mild GI effects possible — take with food

Important Drug interactions

Antibiotics (tetracyclines, quinolones) — zinc reduces absorption; separate by 2 hours
Penicillamine — zinc reduces drug absorption; avoid combination
Iron supplements — zinc and iron compete for absorption; take separately

Featured in these supplement guides

Acid Reflux & GERD→Bloating→

More Gut Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Gut Health
Pancrelipase / Pancreatin
Pancrelipase (also called pancreatin) is a standardized blend of three primary pancreatic…
Gut Health
Sunfiber® (Partially Hydrolyzed Guar Gum)
Sunfiber® is the original and most extensively clinically-studied partially hydrolyzed gua…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…
Muscle & Recovery
Bromelain
Bromelain is a group of protein-digesting enzymes extracted from pineapple stems, used in…

Related articles from our blog

📝 Article
Peptides: Which Are Legal Supplements, and Which Are Not
Peptides are having a moment. They are in face serums and protein powders, in viral videos about "peptide therapy" and w…

Frequently asked questions about PepZinGI® (Zinc-Carnosine for Gut Lining)

What is PepZinGI?

PepZinGI® (NutriScience Innovations) is a unique chelate of zinc and L-carnosine in a 1:1 molar ratio — creating a stable complex that selectively adheres to gastric and intestinal mucosal tissue, providing sustained zinc and carnosine release directly to the gut lining where it exerts its protective, healing, and anti…

What is PepZinGI used for?

PepZinGI is researched primarily for Gut Health. PepZinGI® adheres to gastric and intestinal mucosal epithelium and stimulates tight junction protein expression (claudin-1, occludin, ZO-1) — reducing intestinal permeability ('leaky gut').

What is the recommended dosage of PepZinGI?

The clinically studied dose is 75–150 mg/day PepZinGI® (polaprezinc); 75 mg twice daily for gut lining repair; established pharmaceutical drug in Japan at 150 mg/day for gastric ulcers; supplement dose lower Always follow the product label and check with a healthcare provider for personal advice.

Is PepZinGI safe, and does it have side effects?

For most healthy adults, PepZinGI is well tolerated at studied doses. Reported effects can include: Generally very well tolerated — approved pharmaceutical in Japan with established safety record Zinc content (16 mg per 75 mg dose) — monitor total daily zinc from all sources; UL is 40 mg/day It may also interact with some medications. PepZinGI is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does PepZinGI interact with any medications?

Possible interactions include: Antibiotics (tetracyclines, quinolones) — zinc reduces absorption; separate by 2 hours Penicillamine — zinc reduces drug absorption; avoid combination If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for PepZinGI?

NutraSmarts rates the evidence for PepZinGI as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Mahmood A, FitzGerald AJ, Marchbank T, Ntatsaki E, Murray D, Ghosh S, Playford RJ Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007;56(2):168-75. doi: 10.1136/gut.2006.099929.PubMedUsed to support: Key human/experimental paper behind the gut-lining ('leaky gut') use of zinc-L-carnosine (the PepZin GI compound): oral zinc carnosine stabilized gut mucosa and prevented the ~3-fold rise in intestinal permeability caused by indomethacin. Honest limit: small human component and the broader gut-barrier supplement use rests on smaller studies than the established anti-ulcer drug data.
  2. Shen W, Zhao X, Han Z, Miao Y, Huang H, Zhang Z, Dong L, Nie Y, Li H, Ni R Efficacy and safety of polaprezinc in the treatment of gastric ulcer: A multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial. Medical Engineering & Physics. 2022;110:103860. doi: 10.1016/j.medengphy.2022.103860.PubMedUsed to support: Multicenter randomized controlled trial supporting the strongest evidence base for zinc-L-carnosine/polaprezinc: gastric ulcer healing, where polaprezinc was non-inferior/comparable to rebamipide. Reflects the established Japanese anti-ulcer drug indication rather than the supplement 'gut-health' marketing.
  3. Tan B, Luo HQ, Xu H, Lv NH, Shi RH, Luo HS, Li JS, Ren JL, Zou YY, Li YQ, Ji F, et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. PLoS One. 2017;12(4):e0175625. doi: 10.1371/journal.pone.0175625.PubMedUsed to support: Randomized multicenter trial supporting polaprezinc as an adjunct to H. pylori eradication therapy, improving eradication-related outcomes when added to clarithromycin-based triple therapy. Documents an established adjunctive clinical use of the zinc-carnosine compound.
  4. Watari I, Oka S, Tanaka S, Aoyama T, Imagawa H, Shishido T, Yoshida S, Chayama K Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenterology. 2013;13:108. doi: 10.1186/1471-230X-13-108.PubMedUsed to support: Pilot RCT supporting zinc-L-carnosine/polaprezinc for protecting the small-bowel mucosa against NSAID/low-dose-aspirin injury. Honest limit: small pilot study; consistent with the gut-protective mechanism but not large enough to be definitive, and chronic high-dose zinc intake risks copper deficiency.